Knee osteoarthritis, knee joint pain and aging in relation to increasing serum hyaluronan level in the Japanese population

Osteoarthritis and Cartilage

Volumn 19, Issue 1, 2011, Pages 51-57

  Inoue, R ^a   Ishibashi, Y ^a   Tsuda, E ^a   Yamamoto, Y ^a   Matsuzaka, M ^a   Takahashi, I ^a   Danjo, K ^a   Umeda, T ^a   Nakaji, S ^a   Toh, S ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Biomarker; Health checkups; Japanese; Knee osteoarthritis; Knee pain; Serum hyaluronan

Indexed keywords

BIOLOGICAL MARKER; HYALURONIC ACID;

ADULT; AGING; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BODY MASS; CIGARETTE SMOKING; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FITNESS; HAND RADIOGRAPHY; HEALTH STATUS; HIP RADIOGRAPHY; HUMAN; JAPANESE; KNEE OSTEOARTHRITIS; KNEE PAIN; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; SERUM; VISUAL ANALOG SCALE;

AGED; AGING; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYALURONIC ACID; JAPAN; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX;

EID: 78650310145     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2010.10.021     Document Type: Article

References (48)

1. Tubach F., Ravaud P., Baron G., Falissard B., Logeart I., Bellamy N., et al. Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis 2005, 64:34-37.
2. Lawrence R.C., Helmick C.G., Arnett F.C., Deyo R.A., Felson D.T., Giannini E.H., et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998, 41:778-799.
3. Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16:494-502.
4. Davies-Tuck M.L., Wluka A.E., Wang Y., Teichtahl A.J., Jones G., Ding C., et al. The natural history of cartilage defects in people with knee osteoarthritis. Osteoarthritis Cartilage 2008, 16:337-342.
5. Kamei G., Sumen Y., Sakaridani K. Evaluation of cartilage defect at medial femoral condyle in early osteoarthritis of the knee. Magn Reson Imaging 2008, 26:567-571.
6. Lee C.L., Huang M.H., Chai C.Y., Chen C.H., Su J.Y., Tien Y.C. The validity of in vivo ultrasonographic grading of osteoarthritic femoral condylar cartilage: a comparison with in vitro ultrasonographic and histologic gradings. Osteoarthritis Cartilage 2008, 16:352-358.
7. Tanishi N., Yamagiwa H., Hayami T., Mera H., Koga Y., Omori G., et al. Relationship between radiological knee osteoarthritis and biochemical markers of cartilage and bone degradation (urine CTX-II and NTX-I): the Matsudai Knee Osteoarthritis Survey. J Bone Miner Metab 2009, 27:605-612.
8. Chua S.D., Messier S.P., Legault C., Lenz M.E., Thonar E.J., Loeser R.F. Effect of an exercise and dietary intervention on serum biomarkers in overweight and obese adults with osteoarthritis of the knee. Osteoarthritis Cartilage 2008, 16:1047-1053.
9. Cahue S., Sharma L., Dunlop D., Ionescu M., Song J., Lobanok T., et al. The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis. Osteoarthritis Cartilage 2007, 15:819-823.
10. Bruyere O., Collette J., Kothari M., Zaim S., White D., Genant H., et al. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study. Ann Rheum Dis 2006, 65:1050-1054.
11. Bruyere O., Collette J.H., Ethgen O., Rovati L.C., Giacovelli G., Henrotin Y.E., et al. Biochemical markers of bone and cartilage remodeling in prediction of longterm progression of knee osteoarthritis. J Rheumatol 2003, 30:1043-1050.
12. Cibere J., Zhang H., Garnero P., Poole A.R., Lobanok T., Saxne T., et al. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum 2009, 60:1372-1380.
13. Yatabe T., Mochizuki S., Takizawa M., Chijiiwa M., Okada A., Kimura T., et al. Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes. Ann Rheum Dis 2009, 68:1051-1058.
14. Sabaratnam S., Mason R.M., Levick J.R. Molecular sieving of hyaluronan by synovial interstitial matrix and lymphatic capillary endothelium evaluated by lymph analysis in rabbits. Microvasc Res 2003, 66:227-236.
15. Turan Y., Bal S., Gurgan A., Topac H., Koseoglu M. Serum hyaluronan levels in patients with knee osteoarthritis. Clin Rheumatol 2007, 26:1293-1298.
16. Sharif M., George E., Shepstone L., Knudson W., Thonar E.J., Cushnaghan J., et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 1995, 38:760-767.
17. Georges C., Vigneron H., Ayral X., Listrat V., Ravaud P., Dougados M., et al. Serum biologic markers as predictors of disease progression in osteoarthritis of the knee. Arthritis Rheum 1997, 40:590-591.
18. Pavelka K., Forejtová S., Olejárová M., Gatterová J., Senolt L., Spacek P., et al. Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis. Osteoarthritis Cartilage 2004, 12:277-283.
19. Elliott A.L., Kraus V.B., Luta G., Stabler T., Renner J.B., Woodard J., et al. Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. Arthritis Rheum 2005, 52:105-111.
20. Goldberg R.L., Huff J.P., Lenz M.E., Glickman P., Katz R., Thonar E.J. Elevated plasma levels of hyaluronate in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1991, 34:799-807.
21. Duncan P.W., Weiner D.K., Chandler J., Studenski S. Functional reach: a new clinical measure of balance. J Gerontol 1990, 45:M192-M197.
22. Duncan P., Studenski S., Richards L., Gollub S., Lai S.M., Reker D., et al. Randomized clinical trial of therapeutic exercise in subacute stroke. Stroke 2003, 34:2173-2180.
23. Podsiadlo D., Richardson S. The timed " Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991, 39:142-148.
24. Syddall H.E., Martin H.J., Harwood R.H., Cooper C., Aihie Sayer A. The SF-36: a simple, effective measure of mobility-disability for epidemiological studies. J Nutr Health Aging 2009 Jan, 13:57-62.
25. Roos E.M., Toksvig-Larsen S. Knee injury and Osteoarthritis Outcome Score (KOOS) - validation and comparison to the WOMAC in total knee replacement. Health Qual Life Outcomes 2003, 1:17-26.
26. Bullinger M., Alonso J., Apolone G., Leplège A., Sullivan M., Wood-Dauphinee S., et al. Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol 1998, 51:913-923.
27. Meulenbelt I., Kloppenburg M., Kroon H.M., Houwing-Duistermaat J.J., Garnero P., Hellio Le Graverand M.P., et al. Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study. Ann Rheum Dis 2006, 65:360-365.
28. Kraus V.B., Kepler T.B., Stabler T., Renner J., Jordan J. First qualification study of serum biomarkers as indicators of total body burden of osteoarthritis. PLoS One 2010, 17. e9739.
29. D'Agostino M.A., Conaghan P., Le Bars M., Baron G., Grassi W., Martin-Mola E., et al. EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: prevalence of inflammation in osteoarthritis. Ann Rheum Dis 2005, 64:1703-1709.
30. Zamber R.W., Teitz C.C., McGuire D.A., Frost J.D., Hermanson B.K. Articular cartilage lesions of the knee. Arthroscopy 1989, 5:258-268.
31. Manicourt D.H., Azria M., Mindeholm L., Thonar E.J., Devogelaer J.P. Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum 2006, 54:3205-3211.
32. Wakitani S., Nawata M., Kawaguchi A., Okabe T., Takaoka K., Tsuchiya T., et al. Serum keratan sulfate is a promising marker of early articular cartilage breakdown. Rheumatology (Oxford) 2007, 46:1652-1656.
33. Emlen W., Niebur J., Flanders G., Rutledge J. Measurement of serum hyaluronic acid in patients with rheumatoid arthritis: correlation with disease activity. J Rheumatol 1996, 23:974-978.
34. Engström-Laurent A., Hällgren R. Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 1985, 44:83-88.
35. Khan J.A., Khan F.A., Dilawar M., Ijaz A., Khan N.A., Mehmood T. Serum hyaluronic acid as a marker of hepatic fibrosis. J Coll Physicians Surg Pak 2007, 17:323-326.
36. Hartley J.L., Brown R.M., Tybulewicz A., Hayes P., Wilson D.C., Gillett P., et al. Hyaluronic acid predicts hepatic fibrosis in children with hepatic disease. J Pediatr Gastroenterol Nutr 2006, 43:217-221.
37. Hällgren R., Engström-Laurent A., Nisbeth U. Circulating hyaluronate. A potential marker of altered metabolism of the connective tissue in uremia. Nephron 1987, 46:150-154.
38. Wilkinson C.R., Bower L.M., Warren C. The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasm. Clin Chim Acta 1996, 256:165-173.
39. Manley G., Warren C. Serum hyaluronic acid in patients with disseminated neoplasm. J Clin Pathol 1987, 40:626-630.
40. Engström-Laurent A., Laurent U.B., Lilja K., Laurent T.C. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest 1985, 45:497-504.
41. Criscione L.G., Elliott A.L., Stabler T., Jordan J.M., Pieper C.F., Kraus V.B. Variation of serum hyaluronan with activity in individuals with knee osteoarthritis. Osteoarthritis Cartilage 2005, 13:837-840.
42. Hinghofer-Szalkay H.G., Mekonen W., Rössler A., Schwaberger G., Lamprecht M., Hofmann P. Post-exercise decrease of plasma hyaluronan: increased clearance or diminished production?. Physiol Res 2002, 51:139-144.
43. Rössler A., László Z., Kvas E., Hinghofer-Szalkay H.G. Plasma hyaluronan concentration: no circadian rhythm but large effect of food intake in humans. Eur J Appl Physiol Occup Physiol 1998, 78:573-577.
44. Sudo A., Miyamoto N., Horikawa K., Urawa M., Yamakawa T., Yamada T., et al. Prevalence and risk factors for knee osteoarthritis in elderly Japanese men and women. J Orthop Sci 2008, 13:413-418.
45. Muraki S., Oka H., Akune T., Mabuchi A., En-yo Y., Yoshida M., et al. Prevalence of radiographic knee osteoarthritis and its association with knee pain in the elderly of Japanese population-based cohorts: the ROAD study. Osteoarthritis Cartilage 2009, 17:1137-1143.
46. Ornetti P., Parratte S., Gossec L., Tavernier C., Argenson J.N., Roos E.M., et al. Cross-cultural adaptation and validation of the French version of the Knee injury and Osteoarthritis Outcome Score (KOOS) in knee osteoarthritis patients. Osteoarthritis Cartilage 2008, 16:423-428.
47. Salavati M., Mazaheri M., Negahban H., Sohani S.M., Ebrahimian M.R., Ebrahimi I., et al. Validation of a Persian-version of Knee injury and Osteoarthritis Outcome Score (KOOS) in Iranians with knee injuries. Osteoarthritis Cartilage 2008, 16:1178-1182.
48. Garnero P., Sornay-Rendu E., Arlot M., Christiansen C., Delmas P.D. Association between spine disc degeneration and type II collagen degradation in postmenopausal women: the OFELY study. Arthritis Rheum 2004, 50:3137-3144.